EBIT Margin (Quarterly)

EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues

ADMA Biologics Inc (ADMA) had EBIT Margin of 35.08% for the most recently reported fiscal quarter, ending 2025-06-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-06-30

Income Statement Financials
Revenue	$121.98M
Net Income	$34.22M
Cost of Goods Sold	$54.76M
Gross Profit	$67.23M
Operating Expenses	$79.19M
Operating Income	$42.80M
Non-Operating Income/Expense	$-2.70M
Pre-Tax Income	$40.10M
Normalized Pre-Tax Income	$40.10M
Income after Taxes	$34.22M
Income from Continuous Operations	$34.22M
Consolidated Net Income/Loss	$34.22M
Normalized Income after Taxes	$34.22M
EBIT	$42.80M
EBITDA	$44.98M
Weighted-Average Shares Outstanding (Basic)	241.49M
Weighted-Average Shares Outstanding (Diluted)	248.61M
Earnings per Share (EPS) (Basic)	$0.14
Earnings per Share (EPS) (Diluted)	$0.14
Balance Sheet Financials
Current Assets	$399.56M
Property, Plant, and Equipment	$57.50M
Long-Term Assets	$158.82M
Total Assets	$558.38M
Current Liabilities	$74.94M
Long-Term Debt	$82.70M
Long-Term Liabilities	$85.11M
Total Liabilities	$160.06M
Common Equity	$398.32M
Tangible Shareholders Equity	$394.27M
Shareholders Equity	$398.32M
Common Shares Outstanding	238.57M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$1.46M
Cash Flow from Investing Activities	$-7.25M
Cash Flow from Financial Activities	$-7.08M
Beginning Cash	$103.15M
End Cash	$90.28M
Increase/Decrease in Cash	$-12.86M
Stock-Based Compensation	$9.59M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	5.33
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.17
Debt to Equity Ratio	0.21
Gross Margin	55.11%
Operating Margin	35.08%
EBIT Margin	35.08%
EBITDA Margin	--
Pre-Tax Profit Margin	32.87%
Profit Margin	28.05%
Free Cash Flow	$-5.66M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.22
Inventory Turnover	0.29
Receiveable Turnover	1.11
Days Sales in Receivables	80.96
Return on Equity	8.59%
Return on Tangible Equity	8.68%
Return on Assets	6.13%
Return on Investments	7.11%
Book Value Per Share	$1.67
Free Cash Flow per Share	$-0.02
Operating Cash Flow per Share	$0.01

Data from Zacks Investment Research, Inc.